Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
2.861
+0.101 (3.65%)
Jan 15, 2025, 2:34 PM EST - Market open
Metagenomi Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Metagenomi stock have an average target of 16.67, with a low estimate of 6.00 and a high estimate of 25. The average target predicts an increase of 482.70% from the current stock price of 2.86.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 10, 2024.
Analyst Ratings
The average analyst rating for Metagenomi stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $14 | Strong Buy | Maintains | $7 → $14 | +389.37% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +144.69% | Nov 21, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +424.33% | Nov 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +144.69% | Oct 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +144.69% | Sep 6, 2024 |
Financial Forecast
Revenue This Year
52.32M
from 44.76M
Increased by 16.91%
Revenue Next Year
34.45M
from 52.32M
Decreased by -34.16%
EPS This Year
-2.50
from -20.05
EPS Next Year
-2.69
from -2.50
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 65.1M | 64.1M | 126.2M |
| Avg | 52.3M | 34.5M | 38.6M |
| Low | 43.3M | 9.8M | 9.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 45.5% | 22.4% | 266.3% |
| Avg | 16.9% | -34.2% | 12.0% |
| Low | -3.3% | -81.3% | -71.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.28 | -1.09 | -0.19 |
| Avg | -2.50 | -2.69 | -2.04 |
| Low | -2.78 | -3.52 | -3.53 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.